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Objective: To determine whether women experience signif-
icantly greater anterior cruciate ligament (ACL) laxity in con-
junction with estrogen and progesterone surges during a nor-
mal 28- to 30-day menstrual cycle. 
Design and Setting: Serial estrogen and progesterone lev-
els were measured via radioimmunoassay procedures to iden-
tify the follicular and luteal phases of a subject's menstrual 
cycle and to determine periods of peak hormonal surges. 
Concomitant ACL laxity measures were taken using a knee 
arthrometer. Hormone levels and ACL laxity were assessed on 
days 1, 10, 11, 12, 13, 20, 21, 22, and 23 of the menstrual cycle. 
Day 1 corresponds to the menstrual phase, when estrogen and 
progesterone levels are at their lowest. Days 10 through 13 
correspond to peak estrogen surge (follicular phase), and days 
20 through 23 correspond to peak progesterone surge (luteal 
phase). 
Subjects: Seven active females between the ages of 21 and 
32 years with at least one apparently healthy knee (no known 
knee anomalies) volunteered for participation in this study. 
Each subject stated that she experienced a normal (28- to 
30-day) menstrual cycle and was not currently taking any type 
of hormone therapy (eg, birth control medication). 
More females are participating in sports as a result of Title IX implementation; having become much more 
athletically active, females subsequently have sus-
tained a significant percentage of total sports injuries. I- 4 
Interestingly, it appears that female athletes have a dispropor-
tionately greater incidence of knee injuries than their male 
counterparts.3 According to the NCAA Injury Surveillance 
Survey, females have an increased rate of knee injury and 
anterior cruciate ligament (ACL) rupture compared with males 
in basketball, soccer, and gymnastics.5 The ACL is the most 
commonly disrupted ligament in the knee,6 and its injury is 
occurring at an increasing rate in women's athletics. 
The ACL extends posteriorly and laterally from the area 
anterior to the intercondylar eminence of the tibia to the 
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Measurements: Blood was drawn on days 1, 10, 11, 12, 13, 
20, 21, 22, and 23 of each subject's menstrual cycle, and ACL 
laxity measurements were assessed immediately after the 
blood draws. Estrogen and progesterone levels were deter-
mined via radioimmunoassay procedures, and ACL laxity was 
determined using a knee arthrometer. 
Results: A within-subjects, repeated-measures analysis of 
variance was applied to determine the presence or absence of 
significant differences in ACL laxity values over the course of a 
subject's menstrual cycle. We found a significant difference in 
ACL laxity when comparing baseline levels of estrogen with 
peak levels of estrogen. A significant increase in ACL laxity was 
also noted when comparing baseline levels of progesterone 
with peak levels of progesterone. 
Conclusions: ACL laxity increased significantly throughout 
the menstrual cycle when comparing baseline with peak levels 
of estrogen and progesterone. 
Key Wonts: estrogen, progesterone, knee arthrometer, ra-
dioimmunoassay 
posterior part of the medial surface of the lateral condyle of the 
femur. In general, the ACL prevents the tibia from moving 
anteriorly during weightbearing. It also stabilizes the tibia 
against abnormal internal rotation and serves as a secondary 
restraint against valgus and varus stress. The ACL works in 
conjunction with the thigh muscles, especially the hamstring 
muscle group, to stabilize the knee joint. It is most vulnerable 
to injury when the leg is partially flexed and in a weightbearing 
position, the tibia is externally rotated, and the knee is in a 
valgus position. This is an especially vulnerable position for 
females, who tend to demonstrate greater genu valgum than 
males due to a wider pelvis. Excessive genu valgum may 
predispose an individual to patellofemoral disorders and an 
increased ACL injury risk. 
Typically, the ACL can sustain injury from a direct blow to 
the knee or from a single-plane force. The single-plane injury 
occurs when the lower leg is rotated while the foot is fixed to 
the playing surface, such as when an athlete suddenly decel-
erates, plants, and makes a sharp "cutting" motion, causing an 
isolated tear of the ACL. 
Alarmingly, many female ACL injuries are the result of 
noncontact mechanisms: quick stopping and cutting motions in 
sports such as basketball, soccer, and gymnastics.7 The unusual 
conditions under which the injuries are occurring are bringing 
more attention to female ACL injuries. The mechanism of the 
increased injury rate remains uncertain; however, possible expla-
nations include sex differences in ligament or muscle strength, 
training history, anatomy, and conditioning techniques. 
A hormonal influence on knee joint laxity has been sug-
gested, along with these sex-related factors, as being associated 
with the increased ACL injury rate among female athletes.7,s 
The identification of estrogen and progesterone receptors in the 
fibroblasts of the human ACL suggests that pregnancy-related 
hormones may have an effect on the structure of this ligament. 9 
Unlike her male counterpart, the menstruating athlete experi-
ences cyclical changes in hormone levels throughout her 
reproductive years. The pregnancy-related hormones estrogen 
and progesterone fluctuate throughout the female menstrual 
cycle (Figure 1). 
The duration of the menstrual cycle ranges from 24 to 35 days, 
averaging 28 days. Events occurring during the menstrual cycle 
can be divided into 3 phases: (1) the menstrual phase, (2) the 
follicular phase, and (3) the luteal phase. 10 The menstrual phase is 
caused by a sudden reduction in estrogen and progesterone and 
lasts for approximately the first 5 days of the cycle. The follicular 
phase lasts from days 6 to 13 in a 28-day cycle. It is during this 
phase that the developing follicle increases its secretion of 
estrogens. II Consequently, estrogens are the dominant ovarian 
hormones during this phase of the menstrual cycle. The luteal 
phase of the menstrual cycle is the longest in duration, lasting 
from days 15 to 28 in a 28-day cycle. It is the time between 
ovulation and the onset of the next menses. After ovulation, 
luteinizing hormone secretion stimulates the development of the 
corpus luteum. The corpus luteum then secretes increasing quan-
tities of estrogens, progesterone, and relaxin. II ,12 If fertilization 
and implantation do not occur, the rising levels of these hormones 
will decrease to their initial, lowest levels when the cycle begins. 10 
Although it has been reported that estrogen and progesterone 
receptors have been identified on the ACL,9 to date there is no 
published information available as to whether or not ACL laxity 
changes in response to peak estrogen and progesterone levels 
during the course of the menstrual cycle. The purpose of our study 
was to determine whether females experience significant differ-
ences in ACL laxity in conjunction with estrogen and progester-
one surges during a normal 28- to 30-day menstrual cycle. 
METHODS 
Subjects 
Seven female subjects ranging in age from 21 to 32 years 
(mean age = 26.9 ± 4.2 years, height = 170.5 ± 5.7 cm, 
weight = 62.7 ± 4.9 kg) participated in this study. Disquali-
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Figure 1. Estrogen and progesterone fluctuations throughout the menstrual, follicular, and luteal phases of the normal 28- to 3O-day 
menstrual cycle. 
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conditions: (1) bilateral knee pathology, (2) use of hormone 
therapy, or (3) a 90-degree tubercle-sulcus angle of more than 
10°. All participants stated that they experienced a normal (28-
to 30-day) menstrual cycle. Each participant had at least one 
apparently healthy knee (no known knee anomalies), which 
was used for ACL laxity assessment during the course of the 
study. All participants stated that they were not currently 
taking any type of hormone therapy (eg, birth control medica-
tion) that might affect normal hormone level fluctuations. 
Because of the tendency of females to display a greater 
Q-angle than males, thus predisposing them to excessive genu 
valgum, we decided to eliminate participants with excessive 
genu valgum. To identify excessive genu valgum, a 90-degree 
tubercle-sulcus angle (Figure 2) was measured by palpating the 
transepicondylar axis of the femur and drawing a line perpen-
dicular to that axis, which was compared with a line passing 
through the center of the patella and the tibial tuberosity. An 
angle of 0° has been defined as normal, whereas an angle of 
10° or more is abnormal. 13 All participants had a measured 
90-degree tubercle-sulcus angle of less than 10° (mean tuber-
cle-sulcus angle = 5.1° ± 1.6°). Informed consent was 
received from each subject in accordance with institutional 
review board guidelines from the University of Utah, Salt Lake 
City, UT, and The Orthopedic Specialty Hospital, Murray, UT. 
The investigation was approved by the University of Utah 
Human Investigation Committee and The Orthopedic Specialty 
Hospital. 
Instruments 
A 21-gauge needle was used in conjunction with an 8.5-mL 
Vacutainer (Becton Dickinson Vacutainer Systems, Franklin 
Lakes, NJ) for all blood draws for the purpose of determining 
serial estrogen and progesterone levels. ACL laxity measure-
ments were assessed with the KT-2000 knee arthrometer 
Figure 2. The SO-degree tubercle-sulcus angle is detennined by 
palpating the transeplcondylar axis of the femur and drawing a line 
perpendicular to that axis, which is compared with a line passing 
through the center of the patella and the tibial tuberosity. 
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(MEDmetric, San Diego, CA), and values were plotted on an 
X-Y plotter for 67,89, and 133 N of pull force. 
Procedures 
Each subject reported to The Orthopedic Specialty Hospital, 
Murray, UT on the day of her onset of menses. At this time, a 
blood sample and an ACL laxity measurement were taken. 
Blood samples were immediately taken to the Cottonwood 
Hospital Blood Laboratory, Murray, UT, for radioimmunoas-
say procedures. Estrogen and progesterone levels were re-
corded to the nearest pglmL and nglmL, respectively. Imme-
diately after blood sampling, an ACL laxity measurement was 
taken using the KT-2000 knee arthrometer. Total tibial trans-
lation relative to the femur was plotted graphically on an X-Y 
plotter for 67, 89, and 133 N of force. Displacement was 
recorded to the nearest 0.5 mm for 133 N of force. This same 
procedure was completed on days 10, 11, 12, 13, 20, 21, 22, 
and 23 of the participant's menstrual cycle to determine peak 
levels of estrogen and progesterone during the follicular and 
luteal phases. 
Statistical Analysis 
A within-subjects, repeated-measures analysis of variance 
was used to determine the presence or absence of significant 
differences in knee laxity values over the course of the 
subject's menstrual cycle. Differences were considered statis-
tically significant at an a level of 0.05 or less. All statistical 
analyses were performed using a personal computer and SPSS 
for Windows software (version 6.01, SPSS, Inc, Chicago, IL). 
RESULTS 
Means and standard deviations for estrogen and progester-
one changes, as well as ACL laxity changes, throughout the 
subjects' menstrual cycles are listed in the Table. Phase I 
corresponds to day 1 of the menstrual cycle (menstrual phase) 
and represents baseline levels of estrogen and progesterone. 
Phase II corresponds to days 10 through 13 of the menstrual 
cycle (follicular phase), or peak estrogen surge. Phase III 
corresponds to days 20 through 23 of the menstrual cycle 
(luteal phase), or peak progesterone surge. We found a signif-
icant difference (F1,6 = 3.56, P = .048) in ACL laxity when 
comparing baseline levels of estrogen (Phase I) with peak 
levels of estrogen (Phase II). A significant difference (F 1,6 = 
13.41, P = .006) in ACL laxity was noted when comparing 
baseline levels of progesterone (Phase I) with peak levels of 
progesterone (Phase III) (Figure 3). 
DISCUSSION 
The purpose of our study was to determine whether women 
experience significant differences in ACL laxity in conjunction 
with estrogen and progesterone surges during a normal 28- to 
Hormonal and ACL Laxity Changes Throughout The Menstrual Cycle (Mean ± SD) 
Phase of Menstrual Cycle 
Phase I (menstrual phase) 
Phase II (follicular phase) 
Phase III (luteal phase) 
Estrogen (pg/mL) 
160.00 ::!: 66.24 
778.00 ::!: 255.43* 
395.00 ::!: 134.57* 
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Figure 3. ACL laxity changes throughout phases I, II, and III. 
·Significantly greater than Phase I (P = .048). 
"Significantly greater than Phase I (P = .06). 
30-day menstrual cycle. Estrogen and progesterone plasma 
levels were measured during the 3 phases of a single menstrual 
cycle for 7 women. The follicular and luteal phases of the 
menstrual cycle were identified to establish peak values for 
these hormones. ACL laxity measurements were then com-
pared with the baseline and peak levels of estrogen and 
progesterone. If estrogen and progesterone influence ACL 
laxity, there should be a change in ACL laxity during the 
menstrual cycle. 
Our results support the theory that hormonal changes expe-
rienced during the menstrual cycle may have an increased ACL 
laxity effect in women. In this study, the greatest ACL laxity 
was associated with the luteal phase. The literature shows that, 
during the course of a normal menstrual cycle, women tend to 
experience surging levels of estrogen and progesterone 
throughout the menstrual cycle. II Estrogen and progesterone 
are lowest during the menstrual phase of the cycle. During the 
follicular phase, estrogen levels rise dramatically as a result of 
rising levels of luteinizing hormone, while progesterone re-
mains relatively low. During the luteal phase, progesterone 
levels increase as a result of the development of the corpus 
luteum. IO,11 The results of estrogen and progesterone assays 
obtained in our study agree with the above-mentioned hormone 
fluctuations experienced during the normal menstrual cycle 
(Table). 
Some researchers have speculated that the increased joint 
laxity of females compared with males may contribute to the 
increased incidence of knee injuries among female ath-
letes.14,15 It has also been suggested that pregnancy-related 
hormones, specifically estrogen and progesterone, may have an 
effect in increasing joint laxity.7 The pregnancy-related hor-




14.00 ::!: 5.44* 
ACL Laxity (mm) 
5.6:!: 1.34 
6.4:!: 1.64* 
7.0 ::!: 1.66* 
relaxation of the pubis and pelvis to accommodate the size of 
the fetus and fetal passage during birth. However, there is no 
definitive evidence for thiS. 16 Although it has been speculated 
that the hormones estrogen and progesterone may exhibit an 
increased ligamentous laxity effect, to date no research has 
examined comparisons between ACL laxity values and mea-
sured levels of estrogen, progesterone, or relaxin . 
For a hormone to have an effect, a receptor must be present 
to accommodate that particular hormone. Recent evidence9 
reveals that estrogen and progesterone receptors are present in 
the ACL. More recently, these researchers used in vitro 
experimentation to establish a possible link between estrogen 
levels and fibroblast metabolism. Using rabbit ACLs, they 
found that collagen synthesis by the ACL fibroblasts signifi-
cantly decreased with increasing local estradiol concentration 
in a dose-dependent manner and concluded that estrogen may 
have an effect on the structure of the ACL.8 We found that 
ACL laxity increased with increasing levels of circulating 
estrogen associated with the follicular phase, which supports 
the theory that increased levels of estrogen may have an effect 
on the ACL. In another study,'7 researchers reported a greater 
number of ACL injuries during the ovulatory (follicular) phase 
of the menstrual cycle and concluded that hormone fluctuations 
need to be considered as a possible factor in increased 
incidence of ACL injuries among women. Their data were 
collected via an interviewer-administered questionnaire of 40 
young females. The questionnaire investigated the time of 
injury as compared with the phase of the menstrual cycle. Our 
results agree with the suggestion that, if increased estrogen 
levels result in increased laxity, female athletes may be at 
increased risk for ACL injury during times when these hor-
mones are at peak levels. 
The differences found in our study, comparing ACL laxity 
values between baseline and peak levels of progesterone, 
support the evidence mentioned above8 that fluctuating levels 
of hormones experienced during the menstrual cycle have an 
effect on female ACL laxity. Although significant differences 
were found between ACL laxity and peak levels of estrogen 
and progesterone, it should be noted that no measurements 
(hormone assays or ACL laxity measurements) were taken 
between the days of the follicular phase and the luteal phase 
(approximately days 15 to 20 of the menstrual cycle), and it is 
not known what changes, if any, occurred between the follic-
ular and luteal phases of the menstrual cycle. Because no 
measurements were taken between the follicular and luteal 
phases, the difference in ACL laxity found during the luteal 
phase may actually have occurred earlier or may have been a 
delayed effect of estrogen. It is possible, as well, that increased 
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female ACL laxity could be a combined effect of estrogen and 
progesterone. Future research on this subject should include 
daily ACL laxity measurements throughout the entire men-
strual cycle. 
It is not known whether the differences in ACL laxity were 
the direct result of increased levels of circulating estrogen and 
progesterone. Changes in female ACL laxity may be due to 
conditions other than varying levels of estrogen and proges-
terone, specifically changing levels of relaxin. Relaxin has 
been found in the peritoneal fluid of nonpregnant, midluteal-
phase females at greatly reduced levels, compared with levels 
found during pregnancy, and is thought to be secreted from the 
corpus luteum. II •12 Our study did not measure varying levels of 
relaxin throughout the normal menstrual cycle. Future research 
should examine the possibility of relaxin receptors on the ACL. 
Also, future research should look at relaxin levels, as well as 
the combination of estrogen, progesterone, and relaxin, and the 
relationship to female ACL laxity. 
A number of factors affect displacement of the knee joint: 
starting position of the joint (angle of knee flexion), external 
constraints on motion, applied force (load, direction, and point 
of application), muscle tone (quadriceps and hamstring relax-
ation), and ligament laxity.18 Many investigators have ob-
served that anterior laxity resulting from disruption of the ACL 
is best detected with the knee in 15° to 45° of flexion. 18-21 
Because anterior-posterior laxity is altered by the angle of 
flexion of the knee, it is important that participants are placed 
in the same angle of flexion for each measurement. 18 The thigh 
support used in this study positioned the knee at approximately 
35° of flexion. Both limbs of the participants were positioned 
in the same degree of rotation by means of a footrest, which 
constrained external rotation of the tibia. The base of the 
footrest is scaled, and the starting position of each subject was 
noted and maintained throughout subsequent ACL laxity mea-
surements. Muscle tone was measured by manually assessing 
the participant's quadriceps and hamstrings and verbally in-
structing the subject to relax. Because this technique is fairly 
subjective in nature, it was impossible to ascertain whether true 
muscle relaxation was obtained. The test administrator for this 
investigation was experienced and had previously demon-
strated acceptable intertester and intratester reliability, reduc-
ing the likelihood that the ACL laxity values obtained were 
compromised due to this phenomenon. An intraclass correla-
tion for a single tester for 133 N of force for right leg anterior 
displacement has been reported to be 0.932.22 
CONCLUSIONS 
Although the subject sample size in our study was small, the 
results demonstrate a definite relationship between greater 
female ACL laxity and surging levels of estrogen and proges-
terone during a normal menstrual cycle. Because the women 
who participated in this study exhibited increased ACL laxity 
throughout the course of their menstrual cycle, it cannot be 
concluded that increased laxity increases the risk of ACL 
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injury during these times of peak hormone levels. It is possible 
that increased ACL laxity may actually be the result of a 
protective mechanism designed to allow the ligament to 
elongate rather than rupture, in which case increased levels of 
circulating reproductive hormones may not be a contributing 
factor to increased female ACL ruptures. Because we do not 
yet know whether circulating hormones contribute to the 
increased incidence of ACL injuries, future research on this 
topic should focus on when during the menstrual cycle ACL 
injuries are occurring. 
This is the first known study to examine the relationship 
between female sex hormones and ACL laxity. The results 
demonstrate that female ACL laxity significantly increases in 
conjunction with surging levels of estrogen and progesterone 
during the normal menstrual cycle. Due to the increased 
participation of women in sports and the increased ACL injury 
rate in female athletes compared with males, more research is 
needed to address the causative factors and the role of 
prevention in decreasing the rate of knee injury among female 
athletes. Our results, which indicate the importance of consid-
ering female sex hormones as one of several factors that may 
be contributing to the female ACL injury epidemic, provide 
sound justification for further research in this area. 
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